Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Pediatric Neurosurgery
|
May 13, 1998
Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases
J C Christenson, A T Pavia, K Seskin, et al.
American Journal of Medical Genetics
|
November 14, 2000
Growth failure, intracranial calcifications, acquired pancytopenia, and unusual humoral immunodeficiency: a genetic syndrome?
E E Adderson, D H Viskochil, J C Carey, et al.
Pediatrics
|
July 4, 2001
Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?
E E Adderson, C L Byington, L Spencer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 11, 1992
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer
C L Shapiro, R F Haft, N M Gantz, et al.
American Journal of Infection Control
|
December 10, 1999
Bacillus cereus infections among oncology patients at a children's hospital
J C Christenson, C Byington, E K Korgenski, et al.
The Journal of Infectious Diseases
|
March 1, 1996
Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients
H J Chang, J C Christenson, A T Pavia, et al.
Antiviral Therapy
|
March 21, 2000
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group
L E Chapman, G J Mertz, C J Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
L E Chapman, B A Ellis, F T Koster, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Pediatric Neurosurgery
|
May 13, 1998
Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases
J C Christenson, A T Pavia, K Seskin, et al.
American Journal of Medical Genetics
|
November 14, 2000
Growth failure, intracranial calcifications, acquired pancytopenia, and unusual humoral immunodeficiency: a genetic syndrome?
E E Adderson, D H Viskochil, J C Carey, et al.
Pediatrics
|
July 4, 2001
Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?
E E Adderson, C L Byington, L Spencer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 11, 1992
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer
C L Shapiro, R F Haft, N M Gantz, et al.
American Journal of Infection Control
|
December 10, 1999
Bacillus cereus infections among oncology patients at a children's hospital
J C Christenson, C Byington, E K Korgenski, et al.
The Journal of Infectious Diseases
|
March 1, 1996
Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients
H J Chang, J C Christenson, A T Pavia, et al.
Antiviral Therapy
|
March 21, 2000
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group
L E Chapman, G J Mertz, C J Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
L E Chapman, B A Ellis, F T Koster, et al.
Page
of 3